Loading clinical trials...
Loading clinical trials...
The goal of this research project is to establish that in short-term use, tolvaptan is a safe and potentially effective new therapy for cystinuria, by conducting a short-term pilot study of the safety...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Caleb Nelson
Collaborators
NCT00588562 · Primary Hyperoxaluria, Dent Disease, and more
NCT06065852 · Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, and more
NCT06431893 · Homocystinuria
NCT06495567 · Homocystinuria
NCT03406611 · Homocystinuria
Boston Children's Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions